superstolide A: isolated from the deep water sponge Neosiphonia superstes; made up of a decalin system fused with a 16-membered macrolide; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 10258400 |
CHEMBL ID | 1987099 |
SCHEMBL ID | 15549458 |
MeSH ID | M0242897 |
Synonym |
---|
superstolide a |
nsc-680074 |
7h-napth[2, acetamide deriv. |
156368-64-8 |
nsc680074 |
acetamide,10,14a,16a, 17,18,19,20,20a,20b-decahydro-19-methoxy-3,10,13,13,20b- tetramethyl-7-oxo-7h-naphth[2,1-h]oxacyclohexadecin-9-yl]- 2-hydroxy-1-methylbutyl]-, [9r-[1e,3z,5e,9r*(1r*,2s*,3r*),10r*,11e,13e,14ar*,16ar*,17s*,19s*,20ar*,20br*]]- |
acetamide, n-((1r,2s,3r)-3-((1e,3z,5e,9r,10r,11e,13e,14ar,16ar,17s,19s,20a r,20br)-17-((aminocarbonyl)oxy)-9,10,14a,16a,17,18,19,20,20a,20b-decahydro-19-methoxy-3,10,13,20b-tetramethyl-7-oxo-7h-naphth(2,1-h)oxacyclohexadecin-9-yl)-2-hydroxy-1-methylbu |
nsc 680074 |
acetamide, n-(3-(17-((aminocarbonyl)oxy)-9,10,14a,16a,17,18,19,20,20a,20b-decahydro-19-methoxy-3,10,13,20b-tetramethyl-7-oxo-7h-naphth(2,1-h)oxacyclohexadecin-9-yl)-2-hydroxy-1-methylbutyl)-, (9r-(1e,3z,5e,9r*(1r*,2s*,3r*),10r*,11e,13e,14ar*,16ar*,17s*,19 |
SCHEMBL15549458 |
CHEMBL1987099 |
[(1r,2e,4e,6r,7r,10e,12z,14e,16r,17r,19s,21s,22r)-7-[(2r,3s,4r)-4-acetamido-3-hydroxypentan-2-yl]-19-methoxy-3,6,13,16-tetramethyl-9-oxo-8-oxatricyclo[14.8.0.017,22]tetracosa-2,4,10,12,14,23-hexaen-21-yl] carbamate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 7 (70.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |